Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2007-12-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.298.24.2869PMID 18159056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

  2007influential reference
• Validation study of the lambda model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women

  2007cited by this paper
• Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

  2006cited by this paper
• High proportion of novel mutations ofBRCA1 andBRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain)

  2006cited by this paper
• Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.

  2006cited by this paper
• BRCA1 and BRCA2 mutations in a South American population.

  2006cited by this paper
• Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

  2005cited by this paper
• BRCA1 variants in a family study of African-American and Latina women

  2005cited by this paper
• Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations

  2005cited by this paper
• BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder

  2005cited by this paper
• Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients

  2005cited by this paper
• Breast Cancer and Race: A Rising Tide Does Not Lift All Boats Equally

  2005cited by this paper
• Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• BRCA1 and BRCA2 Mutations in Women from Shanghai China

  2004cited by this paper
• BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.

  2004cited by this paper
• The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

  2004cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2004cited by this paper
• Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

  2004cited by this paper
• Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

  2003cited by this paper
• Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

  2003cited by this paper
• Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early‐onset breast cancer: Identification of three novel pathogenic mutations

  2003cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2003cited by this paper
• Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based study

  2003cited by this paper
• Breast cancer genetics in African Americans

  2003cited by this paper
• Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins

  2002cited by this paper
• Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2

  2002cited by this paper
• Comparison of DNA‐ and RNA‐Based Methods for Detection of Truncating BRCA1 Mutations

  2002cited by this paper
• Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:ψBRCA1 recombination

  2002cited by this paper
• BRCA1/2 genetic testing in the community setting.

  2002cited by this paper
• Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

  2002cited by this paper
• BRCA1 and BRCA2 mutation analysis of early‐onset and familial breast cancer cases in Mexico

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines

  2002cited by this paper
• Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

  2002cited by this paper
• Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

  2001cited by this paper
• The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript

  2001cited by this paper
• Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer

  2000cited by this paper
• Frequency of germ‐line BRCA1 mutations among Spanish families from a Mediterranean area

  2000cited by this paper
• Mutation analysis of BRCA1 gene in African-American patients with breast cancer.

  2000cited by this paper
• The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

  2000cited by this paper
• Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years

  2000cited by this paper
• Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

  2000cited by this paper
• Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• BRCA1 mutations in African Americans

  1999cited by this paper
• A highly accurate, low cost test forBRCA1 mutations

  1999cited by this paper
• BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

  1999cited by this paper
• Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing.

  1998cited by this paper
• Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers

  1998cited by this paper
• BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.

  1998cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

  1997cited by this paper
• BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

  1997cited by this paper
• Multi-stage sampling in genetic epidemiology.

  1997cited by this paper
• Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene

  1996cited by this paper
• Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.

  1993cited by this paper
• Likelihood analysis of multi-state models for disease incidence and mortality.

  1988cited by this paper

• Utilization of Genetic Testing and Surgical Implications in an Ethnically Diverse Hawaiian Population.

  2025cites this paper
• The association of race and ethnicity with risk-reducing mastectomies in patients with non-BRCA mutations.

  2025cites this paper
• The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patients

  2025cites this paper
• Proteogenomic characterization of invasive breast tumors in young women

  2025cites this paper
• All roads lead to mitosis: a common requirement for DNA replication stress-dependent and -independent killing of BRCA-deficient cells.

  2025cites this paper
• The Frequency and Reclassification of Variants Uncertain Significance in Hereditary Breast and Ovarian Cancer Among Levantine Patients

  2025cites this paper
• Patients ask and pathologists answer: ten questions around prostate cancer grading

  2024cites this paper
• Breast Cancer Disparity and Outcomes in Underserved Women.

  2024cites this paper
• Increasing inclusion and equity for Black women in breast cancer clinical trials.

  2024cites this paper
• BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization

  2024cites this paper
• A Retrospective Chart Analysis Comparing Breast Cancer Detection Rates Between Annual Versus Biennial Mammograms

  2024cites this paper
• Racial disparities in treatment and outcomes between Hispanic and non-Hispanic black women with triple-negative breast cancer

  2024influential citation
• Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review

  2024cites this paper
• Gynecologic Care of Black Breast Cancer Survivors

  2024cites this paper
• Germline sequence variation in cancer genes in Rwandan breast and prostate cancer cases

  2024influential citation
• Prostate cancer genotyping for risk stratification and precision treatment

  2024cites this paper
• The effects of Asian American Pacific Islander (AAPI) data inequities in gynecologic oncology.

  2024cites this paper
• Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies

  2023cites this paper
• Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer

  2023influential citation
• A Public Health Emergency: Breast Cancer Among Black Communities in the United States.

  2023cites this paper
• Financial toxicity in BRCA1 and BRCA2 carriers.

  2023cites this paper
• Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients

  2023cites this paper
• Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between.

  2023cites this paper
• Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis

  2023cites this paper
• Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study

  2023cites this paper
• Development of a Hereditary Breast and Ovarian Cancer and Genetics Curriculum for Community Health Workers: KEEP IT (Keeping Each other Engaged Program via IT) Community Health Worker Training

  2023cites this paper
• Association of radiotherapy for stage I–III breast cancer survivors and second primary malignant cancers: a population-based study

  2023cites this paper
• Propensity Score Matching for Bias Reduction in Genomic Profiling.

  2022cites this paper
• Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention

  2022cites this paper
• Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk

  2022cites this paper
• Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer

  2022cites this paper
• Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo‐ECAG) ovarian study

  2022cites this paper
• Estrogen receptor negative breast cancer incidence rates are similar in Ghanaian and Non-Hispanic Black women in the USA

  2022cites this paper
• The BRCAness Landscape of Cancer

  2022cites this paper
• Healthcare Predictors of Information Dissemination About Genetic Risks

  2022cites this paper
• Genetics of Breast Cancer Among Moroccan Women: a Literature Review

  2022cites this paper
• Genetic Testing in the Latinx community: Impact of acculturation and provider relationships.

  2022cites this paper
• Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center

  2022cites this paper
• New Insights Into c.815_824dup Pathogenic Variant of BRCA1 in Inherited Breast Cancer: A Founder Mutation of West African Origin

  2022cites this paper
• Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview

  2022cites this paper
• Behavioral beliefs about genetic counseling among high‐risk Latina breast cancer survivors in Florida and Puerto Rico

  2022cites this paper
• Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.

  2022cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection Version 1 . 2022 —

  2022cites this paper
• Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2‐negative individuals who had genetic testing in a large urban comprehensive cancer center

  2022cites this paper
• Epidemiology of Triple-Negative Breast Cancer: A Review.

  2021cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• Ethnicity/Race and Age-Specific Variations of Serum AMH in Women—A Review

  2021cites this paper
• Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida

  2021cites this paper
• Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities Study

  2021cites this paper
• IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results

  2021cites this paper
• DNA double-strand break repair in cancer: A path to achieving precision medicine.

  2021cites this paper
• A Vision of the Future

  2021cites this paper
• Young Women With Breast Cancer in Brazil: A Population‐Based Study Epidemiology of Breast Cancer in Young Women

  2021cites this paper
• Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study

  2021cites this paper
• Homologous recombination proficiency in ovarian and breast cancer patients

  2021cites this paper
• Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.

  2021cites this paper
• TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

  2020cites this paper
• Screening of germline mutations in young Rwandan patients with breast cancers

  2020influential citation
• A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors

  2020cites this paper
• Closing the Gap: Disparities in Breast Cancer Mortality among African American Women.

  2020cites this paper
• Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women

  2020cites this paper
• Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000–2016

  2020cites this paper
• Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco

  2020cites this paper
• BRCA 1 and BRCA 2 Gene Sequencing in Indonesian Urban Women: Further Study of Noncommunicable Disease Research 2016

  2020cites this paper
• Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

  2020cites this paper
• Socioeconomic Factors Associated with the Receipt of Contralateral Prophylactic Mastectomy in Women with Breast Cancer

  2020cites this paper
• Breast Cancer Health Disparities in Hispanics/Latinas

  2020cites this paper
• EGFR, BRCA1, BRCA2 and TP53 genetic profile in Moroccan triple negative breast cancer cases.

  2020cites this paper
• Efficacy of Neoadjuvant Versus Adjuvant Chemotherapy in Hispanic/Latino (H/L) Women With Local or Locally Advanced Triple-negative Breast Cancer (TNBC)

  2019cites this paper
• Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients

  2019cites this paper
• Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures

  2019cites this paper
• Breast cancer subtypes among Eastern‐African–born black women and other black women in the United States

  2019cites this paper
• Germline genetics in localized prostate cancer.

  2019cites this paper
• BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

  2019cites this paper
• Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study

  2019cites this paper
• CMAR_A_206817 6275..6284

  2019cites this paper
• A pooled analysis of breast-feeding and breast cancer risk by hormone receptor status in parous Hispanic women.

  2019cites this paper
• Genetic Epidemiology of Breast Cancer in Latin America

  2019cites this paper
• Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon

  2019cites this paper
• Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.

  2019cites this paper
• BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells

  2019cites this paper
• Latinas' knowledge of and experiences with genetic cancer risk assessment: Barriers and facilitators.

  2019cites this paper
• Magnitude of Second Contralateral Breast Cancer Risk Reduction with Bilateral Mastectomy in Breast Cancer Patients: Data from California, 1998-2015

  2019cites this paper
• Health and Racial Disparity in Breast Cancer.

  2019cites this paper
• Investigating Variants of Uncertain Significance: Reclassification Triggers and Drivers in Breast Cancer Predisposition Genes

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome

  2019cites this paper
• Oxidative stress and DNA damage in the mechanism of fetal alcohol spectrum disorders

  2019influential citation
• Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia

  2019cites this paper
• Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015

  2019cites this paper
• Markers of BRCAness in breast cancer

  2019cites this paper
• Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?

  2018cites this paper
• Population-Based Cohort Study Reveals Distinct Associations Between Female Lung Cancer and Breast Cancer in Taiwan.

  2018cites this paper
• Mutation Frequencies in Endometrial Cancer Patients of Different Ethnicities and Tumor Grades: An Analytical Study

  2018cites this paper
• Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women

  2018cites this paper
• Molecular markers used in breast cancer diagnosis — current practice and future perspectives

  2018cites this paper
• BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression

  2018cites this paper
• Gynecological–endocrinological aspects in women carriers of BRCA1/2 gene mutations

  2018cites this paper
• Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women

  2018cites this paper
• Seeing Beyond the Margins: Challenges to Informed Inclusion of Vulnerable Populations in Research

  2018cites this paper